Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE
NCT03537638 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 237
Last updated 2021-09-22
Summary
Principal objective: To produce scientific knowledge on the effectiveness and cost-effectiveness of a multicomponent intervention for knowledge transfer and implementing a Clinical Practice Guideline (CPG) for Systemic Lupus Erythematosus (SLE), formed by an educative intervention, an computerized clinical decision support system (SADC), complemented by an automated feedback built into the electronic clinical record.
Secondary objectives will be previously developed: 1) the analysis of medical practice variations along the care of SLE patients in the Canary Islands Health Service (SCS); 2) the best available scientific evidence to support the optimal development of the SADC; 3) the context and the barriers to innovation implementation in the SCS; and 4) the development of the contents for the implementation strategy, including the SADC and the automated feedback.
Methods for the main objective: The main objective will be assessed under an open, multicentric and randomized (by clusters) clinical trial, in the SCS. The multicomponent intervention will be compared to the usual procedures for CPG dissemination. The main measure will be the self-perceived activity of SLE rated by the SLAQ scale. Self-perceived health related quality of life (HRQoL) data will be obtained by means of the questionnaire EQ-5D-5L , to estimate a cost-effectiveness ratio.
Methods for secondary objectives: The rest of the objectives will be developed by a mix of quantitative and qualitative research methods to allow adapting the design, development and execution of the intervention to the characteristics of the context.
Conditions
Interventions
- BEHAVIORAL
-
Multicomponent intervention
Intervention to rheumatologist and internist responsible for the care of patients with SLE. Implementation multicomponent intervention consisting of: educational component, a computerized clinical decision support system developed from the clinical practice guide - SLE and automated feedback integrated into the electronic medical record system.
Sponsors & Collaborators
-
Instituto de Salud Carlos III
collaborator OTHER_GOV -
Servicio Canario de Salud
lead OTHER
Principal Investigators
-
María de Mar Trujillo Martin, PhD · Servicio de Evaluación del Servicio Canario de la Salud
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-16
- Primary Completion
- 2020-10-19
- Completion
- 2020-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
NCT03953690 ·Status: TERMINATED
-
Dissemination of the Lupus Interactive Navigator
NCT02950714 ·Status: COMPLETED ·Phase: NA
-
Belimumab in Patients With Systemic Lupus Erythematosus
NCT04671706 ·Status: NOT_YET_RECRUITING
-
Psycho-social Consequences of Systemic Lupus Erythematosus
NCT03913754 ·Status: COMPLETED
-
Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus
NCT05261529 ·Status: UNKNOWN ·Phase: NA
-
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
NCT06137053 ·Status: RECRUITING
-
Argentinian Prospective Registry of Patients With Lupus
NCT05470569 ·Status: RECRUITING
-
A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.
NCT07053137 ·Status: ACTIVE_NOT_RECRUITING
-
Implementing the Decision-Aid for Lupus (IDEAL Strategy)
NCT03735238 ·Status: COMPLETED
-
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
NCT01405196 ·Status: COMPLETED ·Phase: PHASE2
-
Improving the Assessment of SLE Disease Activity
NCT03144063 ·Status: COMPLETED
-
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
NCT05672576 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Improving Quality of Life for African American Female Adolescents With Lupus
NCT00068874 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy
NCT01765842 ·Status: TERMINATED ·Phase: PHASE3
-
Complete Cognitive Intervention for cSLE
NCT07302113 ·Status: RECRUITING ·Phase: NA
-
A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.
NCT07069972 ·Status: NOT_YET_RECRUITING
-
Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus
NCT00004756 ·Status: COMPLETED ·Phase: NA
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus
NCT05856448 ·Status: COMPLETED ·Phase: PHASE2
-
This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLE
NCT06698900 ·Status: COMPLETED
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE
NCT06720584 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus
NCT05262686 ·Status: UNKNOWN ·Phase: PHASE3
-
Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus
NCT01904812 ·Status: COMPLETED ·Phase: NA
-
Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
NCT02857452 ·Status: COMPLETED